Precisionphage
Helsinki, FI · 1 known investors
Find your way into Precisionphage
Sign up to see every warm intro you have to Precisionphage
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Precisionphage team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PrecisionPhage develops computational and laboratory solutions for bacteriophage research to address antimicrobial resistance. The company creates bioinformatics tools and phage-based technologies intended for healthcare and biotech applications globally.
Founders & leadership
MJ

Matti JalasvuoriChief Executive Officer (CEO)Matti Jalasvuori is CEO of PrecisionPhage, a Finnish biotechnology company developing bacteriophage-based therapies and computational tools to address antibiotic-resistant bacterial infections.
LC

Liisa ChistyFounder
Investors · 1
Frequently asked questions
- What does Precisionphage do?
- PrecisionPhage develops computational and laboratory solutions for bacteriophage research to address antimicrobial resistance. The company creates bioinformatics tools and phage-based technologies intended for healthcare and biotech applications globally.
- Who founded Precisionphage?
- Precisionphage was founded by Saija Kiljunen.
- Who are Precisionphage's investors?
- Precisionphage's investors include Nordic Science Investments.
- Where is Precisionphage headquartered?
- Precisionphage is headquartered in Helsinki, FI.



